Spectro aug 2017
PPMA – events – 2017
Robotics and automation – oct 2017

Latest news

Antabio scoops $8.9m to accelerate cystic fibrosis treatment

Antabio scoops $8.9m to accelerate cystic fibrosis treatment

French biopharma company Antabio has been awarded up to $8.9 million funding from CARB-X, a public-private partnership devoted to antibacterial R&D. The company was selected...
Lilly and Nektar to develop novel autoimmune therapy

Lilly and Nektar to develop novel autoimmune therapy

Eli Lilly and Nektar Therapeutics will, under a new collaboration, co-develop NKTR-358, Nektar’s novel immunological therapy. NKTR-358, which achieved first human dose in Phase 1...
Orchard picks up FDA nod for ‘bubble baby’ treatment

Orchard picks up FDA nod for ‘bubble baby’ treatment

Orchard Therapeutics has picked up a Rare Paediatric Disease Designation for OTL-101, its lead programme for the treatment of ADA-SCID or “bubble baby” disease. OTL-101...